Lgr5 over-expression has been reported in a few cancers[10,12-15], including hepatocellular carcinoma, colorectal cancer, ovarian cancer, basal cell carcinoma, and esophageal adenocarcinoma. Here, LGR5 is linked to esophageal adenocarcinoma.